Research graph
References from Tofacitinib therapy improves disease activity and is associated with the restoration of CD4+ regulatory T cell homeostasis in active Takayasu arteritis: a two-year prospective open-label cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
